Untargeted metabolomics predicts the functional outcome of ischemic stroke
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (1) , 234-241
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology (104-2314-B-038-030, 105-2314-B-038-007, 106-2314-B-038-043, 107-2314-B-038-050)
- Academia Sinica Stroke Biosignature Project (BM10701010021)
- Taiwan MOST Clinical Trial Consortium for Stroke (107-2321-9B-039-004)
This publication has 30 references indexed in Scilit:
- HMDB 3.0—The Human Metabolome Database in 2013Nucleic Acids Research, 2012
- Lipoprotein-Associated Phospholipase A2 Activity Is Associated with Large-Artery Atherosclerotic Etiology and Recurrent Stroke in TIA PatientsCerebrovascular Diseases, 2011
- Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental StrokeTranslational Stroke Research, 2011
- 1 H-NMR-Based Metabolomics Study of Cerebral InfarctionStroke, 2011
- Phosphorylation of Lysophosphatidylcholine Acyltransferase 2 at Ser34 Enhances Platelet-activating Factor Production in Endotoxin-stimulated MacrophagesJournal of Biological Chemistry, 2010
- Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studiesThe Lancet, 2010
- The WEKA data mining softwareACM SIGKDD Explorations Newsletter, 2009
- Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesisJournal of Lipid Research, 2007
- Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic PatientsStroke, 2001
- Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic strokeActa Neurologica Scandinavica, 1992